October 10 (Tue)
October 11 (Wed)
October 12 (Thu)
| Time | Program | Speaker | Affilliation |
|---|---|---|---|
| [Room A] S13: Licensing & BD | |||
| Objectives: This session is designed to support the Licensing & Business Development of Biotech and Pharma Companies with real case studies of Global & Korea’s Pharmaceutical & Bio industry. | |||
| 09:00~12:00 | S13: Licensing & BD | Chair : Myung Kee Kim (LSK Investment), Jaechul Park (StemBank Inc.) |
|
| 09:00~09:10 |
Korean Biotech Investment Market Status
|
Myung Kee Kim | LSK Investment |
| 09:10~09:30 |
Metabolic Disease Portfolio Development and Global Licensing Strategy (Metsera Deal Case)
|
Seulki Lee | D&D Pharmatech |
| 09:30~09:50 |
Strategic New Drug Licensing
|
James JUN | Autotelicbio |
| 09:50~10:10 |
R&BD for Early-Stage Asset in Biotech
|
Jin J. Lim | Bridge Biotherapeutics |
| 10:10~10:30 | Q&A | ||
| 10:30~10:50 |
Late stage development and marketed product licensing
|
Pascal Nizet | Pharmaphenix |
| 10:50~11:10 | Early-Stage Drug Development Collaboration with a Global Pharmaceutical Company | Tomoko Maeda | Boehringer Ingelheim |
| 11:10~11:30 |
Healthcare M&A
|
Jung Eun Choi | Shin & Kim LLC |
| 11:30~11:50 |
New Drug Development through Global Open Innovation
|
Dongkyu (Thierry) UH | DAEWOONG BOSTON INNOVATION HOLDINGS INC. |
| 11:50~12:10 | Business Development & Licensing at MSD | Koji Yashiro | MSD |
| 12:10~12:20 | Q&A | ||
| 12:00~13:30 | Lunch & Sponsor Session(BioForum, Syneos Health, Dreamcis, Clupea) | ||
| [Room B] S14: Advanced Regenerative Medicine | |||
| Objectives: This session is designed to share trends and less learned from clinical development of Advanced Regenerative Medicine. | |||
| 09:00~10:30 | S14: Advanced Regenerative Medicine | Chair : Inho Jo (Korean Fund for Regenerative Medicine (KFRM)) | |
| 09:00~09:20 |
Trends in clinical development of cellular therapeutics; Focusing on the successful IND cases in Korea
|
JONGWAN KIM | S.BIOMEDICS |
| 09:20~09:40 | Stem Cell Therapy for Intractable Neurological Disorders | Kyung Suk Kim | CORESTEMCHEMON |
| 09:40~10:00 |
Lessons Learned from CordSTEM Development
|
Jae Sun Kang | CHA Biotech |
| 10:00~10:20 |
A Path to Acceleration - In Silico Designs in Rare Disease Drug Development
|
Abie Ekangaki | Premier Research |
| 10:20~10:30 | Q&A | ||
| [Room B] S15: Clinical Trials of IVD | |||
| Objectives: This session will feature expert lectures on various aspects of IVD clinical trials and trend for regulation, providing a comprehensive understanding of the process with valuable insights from the fields. | |||
| 10:30~12:00 | S15: Clinical Trials of IVD | Chair : SaeYun Baik (SCL Healthcare), Peter Moon (IMBdx) |
|
| 10:30~11:00 |
Rapid Infectious Disease Testing by Using AI/ML
|
Kwangmin Son | PhAST Corp |
| 11:00~11:25 | The IVDs Approval Policy Trends in Korea Before and After the Pandemic | Seung-yong Lee | Ministry of Food and Drug Safety |
| 11:25~11:50 | Utility of Liquid Biopsy and Circulating Tumor DNA in the Early-Stage Development of Cancer Drugs | Duhee Bang | Yonsei University & IMBdx |
| 11:50~12:00 | Q&A | ||
| [Room C] S16: Next Generation Oncology Drug Development (KCSG Joint Session) | |||
| Objectives: This session will discuss opportunities and new ways of drug development in oncology with Oncologists and Professionals form Korean Cancer Study Group. | |||
| 09:00~12:00 | S16: Next Generation Oncology Drug Development (KCSG Joint Session) | Chair : Do-Youn Oh (Seoul National University Hospital) | |
| 09:00~09:25 |
Development of Next Generation Immunotherapy
|
Hyewon Ryu | Chungnam National University College of Medicine |
| 09:25~09:50 |
Development of Next Generation Targeted Therapy
|
Dong-Hoe Koo | Kangbuk Samsung Hospital |
| 09:50~10:15 |
Development of Next Generation Antibody Drug Conjugate
|
Hyun Ae Jung | Samsung Medical Center |
| 10:15~10:30 | Break | ||
| 10:30~10:55 |
Tissue-Agnostic New Drug Development: When and How
|
In-Ho Kim | Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea |
| 10:55~11:20 |
Case Sharing from KOSMOS-II, a Precision Medicine Trial Led by KCSG
|
Sun Young Kim | University of Ulsan College of Medicine |
| 11:20~11:45 |
Clinical Trials in the Era of Precision Medicine-KCSG Readiness
|
Jee Hyun Kim | Seoul National University Bundang Hospital |
| 11:45~12:00 | Q&A | ||
| 12:00~13:30 | Lunch & Sponsor Session | ||
| [Room A] S17: DTx Clinical Trials | |||
| Objectives: Discuss various aspects of DTx clinical trials | |||
| 13:30~15:00 | S17: DTx Clinical Trials | Chair : Yu, Kyung-Sang (Seoul National University) | |
| 13:30~14:00 |
Digital + Healthcare. Data Is All You Need.
|
Sean G. Kang | WELT Corp. |
| 14:00~14:30 |
DTx Clinical Trials Targeting Elderly Patients
|
Yoo-hun Noh | Emocog Inc. |
| 14:30~15:00 |
Clinical Trials for DTx; How We Can Save Time and Resource?
|
Jaeyong Shin | Yonsei University |
| [Room B] S18: Microbiome | |||
| Objectives: This session will bring together industry and academic leaders in microbiome to share recent developments and strategies of microbiome. | |||
| 13:30~15:00 | S18: Microbiome | Chair : Sang Sun Yoon (Yonsei University College of Medicine, BioMe), SeungHwan Lee (Seoul National University Hospital) |
|
| 13:30~13:50 |
Overview: Application of Microbiome from a Clinician's Perspective
|
Bumjo OH | Seoul Metropolitan Government Seoul National University Boramae Medical Center |
| 13:50~14:20 |
Molecule-First Strategy in Microbiome Therapeutics
|
Sang Sun Yoon | Yonsei University College of Medicine, BioMe |
| 14:20~14:50 |
Microbiome for Therapeutic Development
|
Bo-Gie Yang | GI Biome |
| 14:50~15:00 | Q&A | ||
| [Room C] S19: Big Data / RWE | |||
| Objectives: This Session is to share innovative applications of RWE, how real-world data can be used to assist in study design and as a data source to facilitate clinical research. | |||
| 13:30~15:00 | S19: Big Data / RWE | Chair : Seongsik Kang (DreamCIS), Brian Jo (Evidnet) |
|
| 13:30~13:50 |
Leveraging RWE to Optimize & Transform Clinical Development Research
|
Cynthia Verst | IQVIA |
| 13:50~14:10 |
Real-world data quality and value generation for clinical R&D
|
Subin Lim | Mediplexus |
| 14:10~14:30 |
Predictive and Prognostic Enrichment for Clinical Trials
|
Dominic Marshall | Imperial College London |
| 14:30~14:50 | Establishment of Korean Oncology Real World Evidence | Dae Young Zang | KCSG, KACTC, and HUMC |
| 14:50~15:00 | Q&A | ||
| 15:00~15:30 | Coffee Break | ||
| [Room A] S20: AI in Drug Development | |||
| Objectives: In recent years, there has been considerable focus on AI for drug discovery and development. This session will discuss opportunities and challenges of AI to accelerate the discovery of new drug. | |||
| 15:30~17:00 | S20: AI in Drug Development | Chair : Chang Wook JEONG (Seoul National University Hospital) | |
| 15:30~16:00 |
Artificial Intelligence for De Novo Design of Antibody Drugs
|
Tae-Young Yoon | Seoul National University |
| 16:00~16:30 |
AI in Drug Discovery: Current Practice and Challenges
|
Sang Ok Song | Standigm |
| 16:30~16:50 |
Designing New Drug Combinations for Neurological Disorders
|
Ji-Hyun Lee | DR.Noah Biotech |
| 16:50~17:00 | Q&A | ||
| [Room B] S21: Future of Clinical Trials | |||
| Objectives: In this Session, we will discuss future of clinical trials and solutions to advance clinical trials, enable R&D digital transformation, increase efficiencies, and reduce the burden to patients and investigators. | |||
| 15:30~17:00 | S21: Future of Clinical Trials | Chair : Jin Hyung Lee (Stanford University, LVIS), In-Jin Jang (SNUH) |
|
| 15:30~15:50 |
Real World Data to Generate High-quality External Control Arms Using a Global Federated Network Approach
|
Ben Min-Woo Illigens | BC Platforms |
| 15:50~16:10 | Clinical Trials Using EEG | Jin Hyung Lee | Stanford University, LVIS |
| 16:10~16:30 |
How FDA is Shaping the Future of Clinical Trials
|
Colleen Kuemmel | Kuemmel Consulting |
| 16:30~16:50 |
Predictions Fueling the Future of Clinical Research
|
Min-Gul Kim | Jeonbuk National University Hospital |
| 16:50~17:00 | Q&A | ||
| [Room C] S22: Decentralized Clinical Trial+ Smart Clinical Trial | |||
| Objectives: This session is to explore global and domestic case studies of DCT and how the regulatory authorities and government affiliates correspond to embracing new methodologies. | |||
| 15:30~17:00 | S22: Decentralized Clinical Trial+ Smart Clinical Trial | Chair : Kwunho Jeong (JNPMEDI Inc.), Kyung Hwan Kim (Seoul National University Hospital) |
|
| 15:30~15:50 |
DCT Initiatives in Korea
|
Kyung Hwan Kim | Seoul National University Hospital |
| 15:50~16:10 |
In a Post Pandemic World, Decentralized Clinical Trial Elements are Here to Stay
|
Pamela Tenaerts | Medable |
| 16:10~16:30 |
How Did Digital Technologies Worked in Real Case of DCT Study
|
Kwunho Jeong | JNPMEDI Inc. |
| 16:30~16:50 |
Decentral Clinical Trials Trends
|
Jerome Armellini | IQVIA |
| 16:50~17:00 | Q&A | ||
.png&folder=site)